Sign Up Today and Learn More About Generate Biomedicines Stock
Invest in or calculate the value of your shares in Generate Biomedicines or other pre-IPO companies through EquityZen's platform.
Generate Biomedicines Stock (GEBO)
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
About Generate Biomedicines Stock
Founded
2018
Headquarters
Somerville, MA, US
Industries
Data and Analytics, Science and Engineering, Health Care
Generate Biomedicines Press Mentions
Stay in the know about the latest news on Generate Biomedicines
Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy ...
businesswire • Jun 26, 2024
25. Generate: Biomedicines
cnbc • May 23, 2024
Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer
businesswire • May 23, 2024
Generate:Biomedicines Hires Kym White To Lead Corporate Affairs
provokemedia • May 05, 2024
Protein Engineering Market Size Estimated to Reach USD 15.25 Bn by 2032
globenewswire • May 05, 2024
Generate Biomedicines Management
Leadership team at Generate Biomedicines
Chief Scientific Officer
Michael Nohaile
Co-Founder
Sophie de Boer
Join now and verify your accreditation status to gain access to:
- Generate Biomedicines current valuation
- Generate Biomedicines stock price
- Available deals in Generate Biomedicines and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Generate Biomedicines stock?
Accredited investors can buy pre-IPO stock in companies like Generate Biomedicines through EquityZen funds. These investments are made available by existing Generate Biomedicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Generate Biomedicines stock?
Shareholders can sell their Generate Biomedicines stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
